Short summary of Ark trades for 5/20/2022 ARK is taking advantage of the chance to acquire more GINKGO Bioworks shares. Recently, their investment purchases have gotten increasingly questionable, with ROKU being the largest stake and that in their latest endeavor ,they purchase Ginkgo Bioworks.  A quick google search would turn up some prior short report evidence from Citron and Scoprion Capital in October, as well as some DOJ inquiry following the short report, and that its accounting is a bit hocus pocus. However, the DOJ ruled that the brief report findings were unjustified. It is also worth noting that Bill Gates backed Ginkgo Bioworks (+1 for credibility),  and that its share price has dropped significantly since its inception. The most recent news indicates that Gingko has tripled its revenue (282% to be exact), thus I feel it is worthwhile to take a deeper look at this company , since it appears that they are more than just a standard biotech...